However, the rarity of such alterations in this and in a previous study [21], together with the sequential loss of EPHB2 expression during colorectal carcinogenesis, suggests a limited role for EPHB2 in CRC predisposition and speaks for the more pronounced role for EPHB2 in tumor progression than in tumor initiation. The gene discussed is EPHB2; the disease is colorectal carcinoma.